First human trial tests probiotic pill for autoimmune dryness disease
NCT ID NCT06297213
Summary
This is an early safety study to see if a new oral probiotic called R-2487 is safe and well-tolerated in people with Sjogren's Syndrome. The study will enroll 36 participants who will take the probiotic, and doctors will check for side effects, measure inflammation, and see if it affects their symptoms or quality of life. The main goal is to find a safe dose before testing if it can help control the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SJOGREN'S SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.